Select for export Considerations in assessing the abuse potential of psychedelics during drug development. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.neuropharm.2022.109352 PubMed 36455646 Copy citation Copy BibTeX Unknown journal 2022-11-27 Calderon SN, Bonson KR, Reissig CJ, Lloyd JM, Galati S, Chiapperino D. Europe PMC Published psilocybin Receptor Pharmacology Other More
Select for export The Missing Piece? A Case for Microglia's Prominent Role in the Therapeutic Action of Anesthetics, Ketamine, and Psychedelics. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s11064-022-03772-0 PubMed 36327017 Copy citation Copy BibTeX Unknown journal 2022-11-02 VanderZwaag J, Halvorson T, Dolhan K, Šimončičová E, Ben-Azu B, Tremblay MÈ. Europe PMC Published psilocybin AddictionNeuroplasticityPharmacology Review Article More
Select for export The psychedelic renaissance: can psilocybin possibly combat depression? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1097/gh9.0000000000000089 Copy citation Copy BibTeX International Journal of Surgery Global Health 2022-10-31 Hamna Raheel, Unaiza Naeem, Asim Shaikh, Omer Ahmed Shaikh OpenAlex Published psilocybin DepressionAnxietyPTSD Systematic Review More
Select for export Psilocybin induces acute and persisting alterations in immune status and the stress response in healthy volunteers Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1101/2022.10.31.22281688 Copy citation Copy BibTeX medRxiv 2022-10-31 Mason N, Szabo A, Kuypers K, Mallaroni P, de la Torre Fornell R, Reckweg J medRxiv PREPRINT (not peer reviewed) psilocybin DepressionMechanism of ActionBiomarkers Other More
Select for export Microdosing with classical psychedelics: Research trajectories and practical considerations. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/13634615221129115 PubMed 36317302 Copy citation Copy BibTeX Unknown journal 2022-10-30 Wong A, Raz A. Europe PMC Published psilocybin ConsciousnessMicrodosingCreativity Other More
Select for export Psilocybin modulation of time-varying functional connectivity is associated with plasma psilocin and subjective effects. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.neuroimage.2022.119716 PubMed 36341951 Copy citation Copy BibTeX NeuroImage 2022-10-26 Olsen AS, Lykkebo-Valløe A, Ozenne B, Madsen MK, Stenbæk DS, Armand S Europe PMC Published psilocybinpsilocin Brain ImagingConsciousnessAging Other More
Select for export Potential Therapeutic Effects of Psilocybin: A Systematic Review. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.7759/cureus.30214 PubMed 36381758 Copy citation Copy BibTeX Unknown journal 2022-10-11 Goel DB, Zilate S. Europe PMC Published psilocybin DepressionAnxietyAddiction Systematic Review More
Select for export 19.3 Psilocybin-Assisted Therapy for MDD: Current Evidence and Clinical Considerations No abstract availability was recorded for this entry. Details DOI 10.1016/j.jaac.2022.07.664 Copy citation Copy BibTeX Journal of the American Academy of Child & Adolescent Psychiatry 2022-09-30 Natalie Gukasyan OpenAlex Published psilocybin DepressionAnxietyReceptor Pharmacology Randomized Controlled Trial More
Select for export New investigational agents for the treatment of major depressive disorder. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1080/13543784.2022.2113376 PubMed 35975761 Copy citation Copy BibTeX Expert opinion on investigational drugs 2022-09-30 Pochwat B, Krupa AJ, Siwek M, Szewczyk B PubMed Published psilocybin DepressionMechanism of ActionReceptor Pharmacology Review Article More
Select for export Prevalence and associations of classic psychedelic-related seizures in a population-based sample. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.drugalcdep.2022.109586 PubMed 35981469 Copy citation Copy BibTeX Drug and alcohol dependence 2022-09-30 Simonsson O, Goldberg SB, Chambers R, Osika W, Long DM, Hendricks PS PubMed Published psilocybin AddictionSafety Other More
Select for export Psilocybin Therapy for Treatment Resistant Depression: Prediction of Clinical Outcome by Natural Language Processing Abstract available at the source but not redistributed here. Read at source. Details DOI 10.31234/osf.io/kh3cx Copy citation Copy BibTeX PsyArXiv 2022-09-29 Dougherty RF, Clarke P, Alti M, Kuc J, Schlosser D, Dunlop BW PsyArXiv PREPRINT (not peer reviewed) psilocybin DepressionMechanism of ActionEmotional Processing Clinical Trial More
Select for export Psilocybin Therapy for Treatment Resistant Depression: Prediction of Clinical Outcome by Natural Language Processing Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX PsyArXiv 2022-09-29 Authors unavailable PsyArXiv PREPRINT (not peer reviewed) psilocybin DepressionMechanism of ActionEmotional Processing Clinical Trial More
Select for export The use of classic psychedelics among adults: a Danish online survey study. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1080/08039488.2022.2125069 PubMed 36173202 Copy citation Copy BibTeX Nordic Journal of Psychiatry 2022-09-28 Søgaard Juul T, Ebbesen Jensen M, Fink-Jensen A. Europe PMC Published psilocybin WellbeingSpiritualityMystical Experience Observational Study More
Select for export The Emerging Field of Psychedelic Psychotherapy. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s11920-022-01363-y PubMed 36129571 Copy citation Copy BibTeX Unknown journal 2022-09-20 Barber GS, Aaronson ST. Europe PMC Published psilocybin DepressionPTSDReview Article Review Article More
Select for export The Safety and Efficacy of Psychedelic-Assisted Therapies for Older Adults: Knowns and Unknowns. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.jagp.2022.08.007 PubMed 36184377 Copy citation Copy BibTeX Unknown journal 2022-09-05 Johnston CB, Mangini M, Grob C, Anderson B. Europe PMC Published psilocybin PTSDReceptor PharmacologyAging Clinical Trial More
Select for export Exploring Psychedelics and Entactogens as Treatments for Psychiatric Disorders: Proceedings of a Workshop Abstract available at the source but not redistributed here. Read at source. Details PubMed 36049038 Copy citation Copy BibTeX National Academies Press (US), Washington (DC) 2022-08-31 National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Health Sciences Policy; Forum on Neuroscience and Nervous System Disorders. Europe PMC Published psilocybin DepressionAnxietyPTSD Other More
Select for export A Review of Aeruginascin and Potential Entourage Effect in Hallucinogenic Mushrooms Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX Unknown journal 2022-08-31 Chue P, Andreiev A, Bucuci E, Els C, Chue J. Europe PMC Published psilocybinpsilocin PharmacologyReceptor PharmacologyEpigenetics Review Article More
Select for export Adverse events in clinical treatments with serotonergic psychedelics and MDMA: A mixed-methods systematic review. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811221116926 PubMed 36017784 Copy citation Copy BibTeX Unknown journal 2022-08-25 Breeksema JJ, Kuin BW, Kamphuis J, van den Brink W, Vermetten E, Schoevers RA. Europe PMC Published psilocybin AnxietyHeadache / MigraineClinical Trial Systematic Review More
Select for export Psychedelic drug abuse potential assessment research for new drug applications and Controlled Substances Act scheduling. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.neuropharm.2022.109220 PubMed 35987353 Copy citation Copy BibTeX Unknown journal 2022-08-16 Henningfield JE, Coe MA, Griffiths RR, Belouin SJ, Berger A, Coker AR Europe PMC Published psilocybin Mechanism of ActionConsciousnessSpirituality Other More
Select for export The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: Serotonergic Psychedelic Treatments for Major Depressive Disorder. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/07067437221111371 PubMed 35975555 Copy citation Copy BibTeX Unknown journal 2022-08-16 Rosenblat JD, Husain MI, Lee Y, McIntyre RS, Mansur RB, Castle D Europe PMC Published psilocybin DepressionAnxietyHeadache / Migraine Randomized Controlled Trial More
